The authors demonstrated the association of JARID1B expression with slow-cycling melanoma cells, as previously reported (Roesch et al, 2010), and identified their ability to transition between states with or without JARID1B expression, suggesting a more heterogeneous nature than previously thought (Puig et al, 2018). Here, KDM5B is linked to melanoma.